Literature DB >> 25078619

Genomic aspects of sporadic neurodegenerative diseases.

Jun Mitsui1, Shoji Tsuji2.   

Abstract

Sporadic neurodegenerative diseases are complex in nature, that is, they involve multiple genetic and environmental factors that may play roles at the molecular level. In contrast to diseases with Mendelian inheritance, the genomic signatures of common sporadic forms of neurodegenerative diseases largely remain unknown. Over the past decade, genome-wide association studies employing common single-nucleotide polymorphisms have been intensively conducted, in which the theoretical framework is based on the "common disease-common variants" hypothesis. Another paradigm is a sequence-based association study under the "common disease-multiple rare variants" hypothesis. Because current next-generation sequencing technologies enable us to obtain virtually all the variants in human genome irrespective of allele frequencies, it is anticipated that sequence-based association studies will become the mainstream approach. In this review, we present brief overviews of molecular genetic approaches to elucidate the molecular bases of sporadic forms of neurodegenerative diseases, including Alzheimer disease, Parkinson disease, and multiple system atrophy as examples.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Common disease-multiple rare variants hypothesis; Genome-wide association studies; Next-generation sequencing technologies; Sporadic neurodegenerative disease

Mesh:

Year:  2014        PMID: 25078619     DOI: 10.1016/j.bbrc.2014.07.098

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  UBA1: At the Crossroads of Ubiquitin Homeostasis and Neurodegeneration.

Authors:  Ewout J N Groen; Thomas H Gillingwater
Journal:  Trends Mol Med       Date:  2015-10       Impact factor: 11.951

Review 2.  Mutations, associated with early-onset Alzheimer's disease, discovered in Asian countries.

Authors:  Eva Bagyinszky; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2016-10-17       Impact factor: 4.458

3.  Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS.

Authors:  Vidya Sagar; S Pilakka-Kanthikeel; Paola C Martinez; V S R Atluri; M Nair
Journal:  PLoS One       Date:  2017-08-08       Impact factor: 3.240

4.  The Alu neurodegeneration hypothesis: A primate-specific mechanism for neuronal transcription noise, mitochondrial dysfunction, and manifestation of neurodegenerative disease.

Authors:  Peter A Larsen; Michael W Lutz; Kelsie E Hunnicutt; Mirta Mihovilovic; Ann M Saunders; Anne D Yoder; Allen D Roses
Journal:  Alzheimers Dement       Date:  2017-02-24       Impact factor: 21.566

5.  Gene-expression reversal of lncRNAs and associated mRNAs expression in active vs latent HIV infection.

Authors:  Madhavan Nair; Vidya Sagar; Sudheesh Pilakka-Kanthikeel
Journal:  Sci Rep       Date:  2016-10-19       Impact factor: 4.379

6.  Hippocampal neurophysiology is modified by a disease-associated C-terminal fragment of tau protein.

Authors:  Francesco Tamagnini; Darren A Walsh; Jon T Brown; Marie K Bondulich; Diane P Hanger; Andrew D Randall
Journal:  Neurobiol Aging       Date:  2017-07-20       Impact factor: 4.673

Review 7.  Transcriptional Dynamics at Brain Enhancers: from Functional Specialization to Neurodegeneration.

Authors:  Marit W Vermunt; Menno P Creyghton
Journal:  Curr Neurol Neurosci Rep       Date:  2016-10       Impact factor: 5.081

8.  Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines.

Authors:  Masaru Tanaka; József Toldi; László Vécsei
Journal:  Int J Mol Sci       Date:  2020-03-31       Impact factor: 5.923

Review 9.  Interplay of RNA-Binding Proteins and microRNAs in Neurodegenerative Diseases.

Authors:  Chisato Kinoshita; Noriko Kubota; Koji Aoyama
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.